Jan Steyn

1.6k total citations · 1 hit paper
6 papers, 1.2k citations indexed

About

Jan Steyn is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Jan Steyn has authored 6 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Emergency Medicine. Recurrent topics in Jan Steyn's work include HIV/AIDS Research and Interventions (5 papers), HIV Research and Treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Jan Steyn is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), HIV Research and Treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Jan Steyn collaborates with scholars based in South Africa, United States and Mongolia. Jan Steyn's co-authors include James McIntyre, Diana M. Gibb, Abdel G. Babiker, Mark F. Cotton, Avy Violari, Patrick Jean‐Philippe, Shabir A. Madhi, Glenda Gray, Neil Martinson and Lynn Morris and has published in prestigious journals such as New England Journal of Medicine, AIDS and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Jan Steyn

6 papers receiving 1.1k citations

Hit Papers

Early Antiretroviral Therapy and Mortality among HIV-Infe... 2008 2026 2014 2020 2008 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Steyn South Africa 5 1.1k 619 351 225 211 6 1.2k
Rawiwan Hansudewechakul Thailand 17 685 0.7× 346 0.6× 229 0.7× 267 1.2× 113 0.5× 64 874
Janneke H. van Dijk United States 16 658 0.6× 308 0.5× 221 0.6× 142 0.6× 197 0.9× 28 804
Ndèye Fatou Ngom Gueye Senegal 14 915 0.9× 521 0.8× 329 0.9× 240 1.1× 115 0.5× 31 1.1k
Patricia Fassinou France 13 766 0.7× 347 0.6× 316 0.9× 174 0.8× 174 0.8× 23 836
Elizabeth Obimbo Kenya 18 588 0.6× 342 0.6× 301 0.9× 126 0.6× 106 0.5× 30 812
C Bhadrakom United States 7 790 0.8× 399 0.6× 389 1.1× 168 0.7× 251 1.2× 10 891
Ariane Alimenti Canada 17 629 0.6× 327 0.5× 321 0.9× 280 1.2× 141 0.7× 36 947
Paola Germano Italy 14 522 0.5× 263 0.4× 198 0.6× 150 0.7× 107 0.5× 25 635
Claire Moffat United States 12 621 0.6× 301 0.5× 229 0.7× 161 0.7× 101 0.5× 17 788
Mutsa Bwakura‐Dangarembizi Zimbabwe 17 636 0.6× 312 0.5× 202 0.6× 187 0.8× 113 0.5× 64 932

Countries citing papers authored by Jan Steyn

Since Specialization
Citations

This map shows the geographic impact of Jan Steyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Steyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Steyn more than expected).

Fields of papers citing papers by Jan Steyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Steyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Steyn. The network helps show where Jan Steyn may publish in the future.

Co-authorship network of co-authors of Jan Steyn

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Steyn. A scholar is included among the top collaborators of Jan Steyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Steyn. Jan Steyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Martinson, Neil, Lynn Morris, Jeffrey A. Johnson, et al.. (2009). Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS. 23(7). 809–816. 17 indexed citations
2.
Violari, Avy, Mark F. Cotton, Diana M. Gibb, et al.. (2008). Early Antiretroviral Therapy and Mortality among HIV-Infected Infants. New England Journal of Medicine. 359(21). 2233–2244. 1037 indexed citations breakdown →
3.
Martinson, Neil, Didier Koumavi Ekouévi, François Dabis, et al.. (2007). Transmission Rates in Consecutive Pregnancies Exposed to Single-Dose Nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 206–209. 25 indexed citations
4.
Martinson, Neil, Lynn Morris, Glenda Gray, et al.. (2006). Selection and Persistence of Viral Resistance in HIV-Infected Children After Exposure to Single-Dose Nevirapine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 148–153. 71 indexed citations
5.
Martinson, Neil, Tanvier Omar, Glenda Gray, et al.. (2006). High rates of HIV in surgical patients in Soweto, South Africa: impact on resource utilisation and recommendations for HIV testing. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(2). 176–182. 13 indexed citations
6.
Kotzé, H F, et al.. (1990). The sensitivity of tests to detect in vivo platelet activation induced by the removal of arterial endothelium of the baboon (Papio ursinus).. PubMed. 78(5). 271–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026